Terms: = Endocrine gland cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
130 results:
1. The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with prognosis in Patients with Ovarian cancer.
Hjortebjerg R; Høgdall C; Hansen KH; Høgdall E; Frystyk J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396692
[TBL] [Abstract] [Full Text] [Related]
2. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
[TBL] [Abstract] [Full Text] [Related]
3. Short- and long-term outcomes of robotic versus open radical antegrade modular pancreatosplenectomy: a retrospective propensity score-matched cohort study.
Song Y; Zou W; Gao Y; Zhao Z; Yin Z; Xiao C; Liu Q; Liu R
Surg Endosc; 2024 Mar; 38(3):1316-1328. PubMed ID: 38110793
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract] [Full Text] [Related]
5. Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma.
Miyazawa M; Hirono S; Kawai M; Okada KI; Kitahata Y; Motobayashi H; Sato M; Yoshimura T; Ueno M; Hayami S; Miyamoto A; Shimizu A; Yamaue H
Eur J Surg Oncol; 2023 Oct; 49(10):106960. PubMed ID: 37353425
[TBL] [Abstract] [Full Text] [Related]
6. Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas.
Mo S; Zou L; Hu Y; Chang X; Chen J
Mod Pathol; 2023 Sep; 36(9):100223. PubMed ID: 37244388
[TBL] [Abstract] [Full Text] [Related]
7. Modified artery-first approach for distal pancreatectomy with celiac axis resection.
Wang H; Shen S; Ren Y; Lin X; Shi X; Gao S; Li B; Yin X; Zhang G; Liu W; Wang J; Han J; Zhu L; Xu X; Shao Z; Jing W; Song B; Cheng P; Guo S; Zheng K; Jin G
BJS Open; 2023 May; 7(3):. PubMed ID: 37146207
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of the preoperative and early trends in postoperative serum thyroglobulin antibody levels among patients with papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Xu S; Huang H; Qian J; Wang X; Xu Z; Liu S; Liu J
Endocrine; 2023 May; 80(2):392-398. PubMed ID: 36534327
[TBL] [Abstract] [Full Text] [Related]
9. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
10. Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography.
Peng C; Yi D; Zhou Y; Yao J; Chen B; Yang C; Xu D
BMC Cancer; 2022 Aug; 22(1):938. PubMed ID: 36042430
[TBL] [Abstract] [Full Text] [Related]
11. Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian cancer: A Real-World Evidence Study.
Kim SI; Lim H; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Lee M
Cancer Res Treat; 2023 Jan; 55(1):245-257. PubMed ID: 35879854
[TBL] [Abstract] [Full Text] [Related]
12. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
Mego M; Svetlovska D; Angelis V D; Kalavska K; Lesko P; Makovník M; Obertova J; Orszaghova Z; Palacka P; Rečková M; Rejlekova K; Z SM; Mardiak J; Chovanec M
Invest New Drugs; 2022 Oct; 40(5):1080-1086. PubMed ID: 35763178
[TBL] [Abstract] [Full Text] [Related]
13. Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer.
Zhang X; Kong W; Gao M; Huang W; Peng C; Huang Z; Xie Z; Guo H
J Cell Mol Med; 2022 Jul; 26(13):3659-3674. PubMed ID: 35735060
[TBL] [Abstract] [Full Text] [Related]
14. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
Yamai T; Ikezawa K; Hiraga E; Kawamoto Y; Hirao T; Higashi S; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Takada R; Nakabori T; Fukutake N; Uehara H; Fujita M; Ohkawa K
PLoS One; 2022; 17(3):e0264653. PubMed ID: 35231078
[TBL] [Abstract] [Full Text] [Related]
15. Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.
Masui T; Nagai K; Anazawa T; Sato A; Uchida Y; Nakano K; Yogo A; Kaneda A; Nakamura N; Yoshimura M; Mizowaki T; Uza N; Fukuda A; Matsumoto S; Kanai M; Isoda H; Mizumoto M; Seo S; Hata K; Taura K; Kawaguchi Y; Takaori K; Uemoto S; Hatano E
BMC Cancer; 2022 Jan; 22(1):119. PubMed ID: 35093003
[TBL] [Abstract] [Full Text] [Related]
16. High Mast Cell Density Predicts a Favorable prognosis in Patients with Pancreatic Neuroendocrine Neoplasms.
Mo S; Zong L; Chen X; Chang X; Lu Z; Yu S; Chen J
Neuroendocrinology; 2022; 112(9):845-855. PubMed ID: 34963123
[TBL] [Abstract] [Full Text] [Related]
17. Adrenocortical cancer: A 20-Year Experience of a Single Referral Center in prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract] [Full Text] [Related]
18. High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma.
Ghafour AA; Odemis DA; Tuncer SB; Kurt B; Saral MA; Erciyas SK; Erdogan OS; Celik B; Saip P; Yazici H
J Ovarian Res; 2021 Oct; 14(1):131. PubMed ID: 34629107
[TBL] [Abstract] [Full Text] [Related]
19. Multimodal Treatment of Primary Advanced Ovarian cancer.
Friedrich M; Friedrich D; Kraft C; Rogmans C
Anticancer Res; 2021 Jul; 41(7):3253-3260. PubMed ID: 34230119
[TBL] [Abstract] [Full Text] [Related]
20. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
Ouh YT; Kang D; Kim H; Lee JK; Hong JH
Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
[TBL] [Abstract] [Full Text] [Related]
[Next]
